Vincent J. Milano

2016

In 2016, Vincent J. Milano earned a total compensation of $1.4M as President and Chief Executive Officer at Idera Pharmaceuticals, a 54% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$211,680
Option Awards$573,780
Salary$600,000
Other$31,555
Total$1,417,015

Milano received $600K in salary, accounting for 42% of the total pay in 2016.

Milano also received $211.7K in non-equity incentive plan, $573.8K in option awards and $31.6K in other compensation.

Rankings

In 2016, Vincent J. Milano's compensation ranked 6,537th out of 14,075 executives tracked by ExecPay. In other words, Milano earned more than 53.6% of executives.

ClassificationRankingPercentile
All
6,537
out of 14,075
54th
Division
Manufacturing
2,414
out of 5,489
56th
Major group
Chemicals And Allied Products
786
out of 1,895
59th
Industry group
Drugs
600
out of 1,538
61st
Industry
Biological Products, Except Diagnostic Substances
111
out of 279
60th
Source: SEC filing on April 28, 2017.

Milano's colleagues

We found six more compensation records of executives who worked with Vincent J. Milano at Idera Pharmaceuticals in 2016.

2016

Sudhir Phil

Idera Pharmaceuticals

President of Research

2016

Mark Casey

Idera Pharmaceuticals

General Counsel

2016

R Fletcher

Idera Pharmaceuticals

Senior Vice President, Business Development and Strategy

2016

Louis Arcudi

Idera Pharmaceuticals

Chief Financial Officer

2016

Joanna Horobin

Idera Pharmaceuticals

Chief Medical Officer

2016

John Kirby

Idera Pharmaceuticals

Vice President of Finance, Principal Financial and Accounting Officer

News

You may also like